ESC 2021: Late-breaking Science Video Collection

Published: 02 September 2021

  • Views:

    Views Icon 6256

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provide a concise analysis of the late-breaking science results and spotlight impactful data. 

For a deeper dive into key clinical trial data, Dr Harriette Van Spall (McMaster University, Hamilton, CA) interviewed principal investigators on their studies, learnings, and applicability to clinical practice in her regular Late-Breaker Discussion Series. 

Short, accessible Expert Interviews were conducted with select faculty focusing on the results, applicability, and impact on future research.

More from this programme

Part 1

View from the Thoraxcenter

In the latest episode View from the Thoraxcenter, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their concise analysis of the hot line and late-breaking trials that will be presented at ESC Congress 2021. What presentations should we look at for this weekend? Get your update on the importance of trials such as GUIDE-HF, MASTER DAPT, TOMAHAWK and many more delivered by our world-class experts, Professor Van Mieghem and Dr Joost Daemen.
2 sessions
View from the Thoraxcenter – What's Hot at ESC 2021 Watch now
View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up Watch now

Part 2

Late-breaker Discussion Series

Host, Dr Harriette Van Spall interviews the late-breaker and hot line presenters of ESC Congress 2021.
3 sessions
ESC 2021 Discussion: The EMPEROR-Preserved Trial Watch now
ESC 2021 Discussion: The FIGARO-DKD Trial Watch now
ESC 2021 Discussion: The EMPEROR-Pooled Study Watch now

Part 3

Expert Interviews

Short, accessible Expert Interviews were conducted with select faculty focusing on the results, applicability, and impact on future research.
11 sessions
ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI Watch now
SYNTAX II Trial: 5yr Data Shows Reduction in MACE in PCI Watch now
TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI Watch now
The LAAOS III Study: Surgical AFIB Ablation Evaluation Watch now
TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type Watch now
STOPDAPT-2 ACT: 1-Month DAPT Followed by Clopidogrel Monotherapy in ACS Watch now
SPLENDOR: Metabolic Surgery and Risk of MACE in NASH Watch now
RESPONSE-2: Benefits of Community-based Lifestyle Programme Were Lost After 1yr in CAD Patients Watch now
VOYAGER PAD: Rivaroxaban in Symptomatic PAD With & Without Comorbid Diabetes Watch now
Micra CED: 2-Year Outcomes with Leadless Pacing Watch now
RIPCORD 2: FFR During Angiography Did Not Improve Patient Outcomes Watch now

Part 4

Masterclass with Dr Harriette Van Spall & Dr Birgit Vogel

In the ESC Congress 2021 episode of the Masterclass video series, host, Dr Harriette Van Spall (McMaster University, CA) meets with Dr Birgit Vogel (Icahn School of Medicine at Mount Sinai, US), one of the commissioners and first author of the "The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030" report.
1 session
Masterclass on The Global Burden of CV Disease in Women Watch now

Faculty Biographies

Bertram Pitt

Professor in the Department of Internal Medicine

View full profile
Harriette Van Spall

Harriette Van Spall

Associate Professor of Medicine, Director of E-Health and Virtual Care

Dr Harriette Van Spall is an Associate Professor of Medicine and cardiologist and serves as Director of E-Health at McMaster University, Canada. She completed her medical and postgraduate clinical training at the University of Toronto and earned a Master of Public Health degree at Harvard University, US. Dr Van Spall is a Canadian Institutes of Health Research-funded clinical trialist and researcher with a focus on heart failure, health services, and health disparities.

She has garnered more than $4 million in research funding, has won several research awards, and has published her work in high-impact medical journals. She is an invited speaker, media correspondent, and editorial board member active in peer review at several high-impact medications journals and grant funding agencies, including Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada.

Dr Van Spall is an Editorial Board…

View full profile